Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 21, 2025Frontiers in EndocrinologyOpen Access

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAndrijana KocevaUniversity of MariborKKKatarina Mlekuš KozamernikLjubljana University Medical CentreAJAndrej JanežAlbert Einstein College of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Koceva et al. (2025) studied this question.

synapsesocial.com/papers/6aa12e648226d5fab0b569e6https://doi.org/10.3389/fendo.2024.1528457
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management2015 · 2,708 citations
  2. 2Quality of life and psychological well‐being in GH‐treated, adult PWS patients: a longitudinal study2007 · 58 citations
  3. 3Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome2020 · 33 citations
  4. 4In vivo neuroimaging evidence of hypothalamic alteration in Prader–Willi syndrome2022 · 29 citations
  5. 5Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader–Willi syndrome2005 · 92 citations